Paper41836722
Magnesium Oxide Nanoparticles Loaded with 6-Gingerol: A Bioinspired Approach to Anticancer, Anti-Inflammatory, and Antioxidant Therapy.
Kamaraj C and 6 others. Int J Nanomedicine, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Magnesium Oxide Nanoparticles Loaded with 6-Gingerol: A Bioinspired Approach to Anticancer, Anti-Inflammatory, and Antioxidant Therapy. Papers, record 41836722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41836722
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Magnesium Oxide Nanoparticles Loaded with 6-Gingerol: A Bioinspired Approach to Anticancer, Anti-Inflammatory, and Antioxidant Therapy.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Catechols | Major topic |
| Fatty Alcohols | Major topic |
| Antioxidants | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Antineoplastic Agents | Major topic |
| Magnesium Oxide | Major topic |
| Nanoparticles | Major topic |
| Metal Nanoparticles | Major topic |
| Humans | |
| Cell Survival | |
| Cell Line, Tumor | |
| Particle Size | |
| THP-1 Cells | |
| Zingiber officinale | |
| Picrates | |
| Biphenyl Compounds | |
| Apoptosis |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 2 | 30659535 | Ginger: A Novel Strategy to Battle Cancer through Modulating Cell Signalling Pathways: A Review. | Curr Pharm Biotechnol | 2019 | https://conductscience.org/library/papers/30659535 | PubMed |
| 3 | 33802102 | Silk Fibroin Coated Magnesium Oxide Nanospheres: A Biocompatible and Biodegradable Tool for Noninvasive Bioimaging Applications. | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/33802102 | PubMed |
| 4 | 30587976 | Eco-friendly synthesis, characterization, in vitro and in vivo anti-inflammatory activity of silver nanoparticle-mediated Selaginella myosurus aqueous extract. | Int J Nanomedicine | 2018 | https://conductscience.org/library/papers/30587976 | PubMed |
| 5 | 35481029 | Potentialities of bioinspired metal and metal oxide nanoparticles in biomedical sciences. | RSC Adv | 2021 | https://conductscience.org/library/papers/35481029 | PubMed |
| 6 | 24060863 | Cancer drug resistance: an evolving paradigm. | Nat Rev Cancer | 2013 | https://conductscience.org/library/papers/24060863 | PubMed |
| 7 | 23485231 | Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. | Eur J Cancer | 2013 | https://conductscience.org/library/papers/23485231 | PubMed |
| 8 | 36903753 | Smart Magnetic Drug Delivery Systems for the Treatment of Cancer. | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/36903753 | PubMed |
| 9 | 30010317 | Keratin-Templated Synthesis of Metallic Oxide Nanoparticles as MRI Contrast Agents and Drug Carriers. | ACS Appl Mater Interfaces | 2018 | https://conductscience.org/library/papers/30010317 | PubMed |
| 10 | 23717767 | Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: review of current evidence. | Int J Prev Med | 2013 | https://conductscience.org/library/papers/23717767 | PubMed |
| 11 | 32226420 | Comparative Study on the Fungicidal Activity of Metallic MgO Nanoparticles and Macroscale MgO Against Soilborne Fungal Phytopathogens. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32226420 | PubMed |
| 12 | 30470922 | Fabrication of 6-gingerol, doxorubicin and alginate hydroxyapatite into a bio-compatible formulation: enhanced anti-proliferative effect on breast and liver cancer cells. | Chem Cent J | 2018 | https://conductscience.org/library/papers/30470922 | PubMed |
| 13 | 31642855 | Preventing fungal growth on heritage paper with antifungal and cellulase inhibiting magnesium oxide nanoparticles. | J Mater Chem B | 2019 | https://conductscience.org/library/papers/31642855 | PubMed |
| 14 | 38433568 | Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight. | Phytother Res | 2024 | https://conductscience.org/library/papers/38433568 | PubMed |
| 15 | 29462602 | 6-Shogaol induces caspase-independent paraptosis in cancer cells via proteasomal inhibition. | Exp Cell Res | 2018 | https://conductscience.org/library/papers/29462602 | PubMed |
| 16 | 32518846 | Multifunctional properties of spherical silver nanoparticles fabricated by different microbial taxa. | Heliyon | 2020 | https://conductscience.org/library/papers/32518846 | PubMed |
| 17 | 25213983 | Preparative separation and purification of gingerols from ginger (Zingiber officinale Roscoe) by high-speed counter-current chromatography. | Food Chem | 2011 | https://conductscience.org/library/papers/25213983 | PubMed |
| 18 | 21140179 | Fabrication and growth mechanism of ZnO nanostructures and their cytotoxic effect on human brain tumor U87, cervical cancer HeLa, and normal HEK cells. | J Biol Inorg Chem | 2011 | https://conductscience.org/library/papers/21140179 | PubMed |
| 19 | 35054441 | Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile. | Life (Basel) | 2021 | https://conductscience.org/library/papers/35054441 | PubMed |
| 20 | 30453162 | Fabrication of MgO nanostructures and its efficient photocatalytic, antibacterial and anticancer performance. | J Photochem Photobiol B | 2019 | https://conductscience.org/library/papers/30453162 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41836722
GET https://conductscience.org/api/papers/v1/41836722/references?page=2